- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Q linea AB (QLINEA)
Q linea AB stock price live, this page displays ST QLINEA stock exchange data. View the QLINEA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Q linea AB real time stock price chart below.
What Is the Q linea AB Stock Price Today?
The Q linea AB stock price today is 16.75.
What Is the Stock Symbol for Q linea AB?
The stock symbol for Q linea AB is "QLINEA."
What Stock Exchange Does Q linea AB Trade On?
Q linea AB is listed and trades on the Stockholm stock exchange.
Is Q linea AB a Good Stock to Buy?
Determining whether Q linea AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the QLINEA quote. (ISIN: SE0025420714)
What Is the Q linea AB Stock Price Today?
The Q linea AB stock price today is 16.75.
What Is the Stock Symbol for Q linea AB?
The stock symbol for Q linea AB is "QLINEA."
What Stock Exchange Does Q linea AB Trade On?
Q linea AB is listed and trades on the Stockholm stock exchange.
Is Q linea AB a Good Stock to Buy?
Determining whether Q linea AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the QLINEA quote. (ISIN: SE0025420714)
16.75
+0.05(+0.30%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.75
17.15
52 wk Range
14.55
62.60
QLINEA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.7517.15
52 wk Range
14.5562.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
QLINEA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Q linea AB Earnings Call Summary for Q2/2026
- Q-linea narrowed Q2 2026 operating loss to SEK -31.3M from SEK -47.4M YoY; net sales rose 200% to SEK 1.5M; stock gained 6.8% in premarket.
- Company completed restructuring, consolidated to single Swedish site; ended quarter with SEK 187M cash and 24 contracted ASTar instruments vs. 12 YoY.
- FDA approved expanded ASTar menu now fully rolled out to U.S. customers; isolate non-blood test launch remains on track for Q3 2026.
- Management expects monthly operating expenses below SEK 11M in H2 2026; U.S. growth to come primarily from new contracts, not existing site utilization.
- Revenue remains minimal despite 200% growth; consumable sales per instrument declined YoY to SEK 266K, signaling potential utilization challenges.
Last Updated: 2026/07/10, 13:38
Read Full TranscriptEarnings
Latest Release
Jul 10, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / 16,9M
Compare QLINEA to Peers and Sector
Metrics to compare | QLINEA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQLINEAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | 12.1x | −0.4x | |
PEG Ratio | 0.13 | 0.02 | 0.00 | |
Price/Book | 1.2x | 1.6x | 2.6x | |
Price / LTM Sales | 21.9x | 2.2x | 3.0x | |
Upside (Analyst Target) | 199.4% | 3.5% | 53.2% | |
Fair Value Upside | Unlock | 24.6% | 9.5% | Unlock |
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland. It offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert. The company also develops Podler, a portable blood culture technology. It serves physicians, hospitals, laboratories, healthcare payers, and the medical profession. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Q linea (QLINEA) Stock Price Today?
The Q linea stock price today is 16,75 SEK.
What Stock Exchange Does Q linea Trade On?
Q linea is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Q linea?
The stock symbol for Q linea is "QLINEA."
What Is the Q linea Market Cap?
As of today, Q linea market cap is 317,39M SEK.
What Is Q linea's Earnings Per Share (TTM)?
The Q linea EPS (TTM) is -22,91.
When Is the Next Q linea Earnings Date?
Q linea will release its next earnings report on Oct 30, 2026.
From a Technical Analysis Perspective, Is QLINEA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Q linea Stock Split?
Q linea has split 1 times.
How Many Employees Does Q linea Have?
Q linea has 73 employees.
What is the current trading status of Q linea (QLINEA)?
As of Jul 15, 2026, Q linea (QLINEA) is trading at a price of 16,75 SEK, with a previous close of 16,70 SEK. The stock has fluctuated within a day range of 16,75 SEK to 17,15 SEK, while its 52-week range spans from 14,55 SEK to 62,60 SEK.
What Is Q linea (QLINEA) Price Target According to Analysts?
The average 12-month price target for Q linea is 50,00 SEK, with a high estimate of 50 SEK and a low estimate of 50 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +198,51% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.